[go: up one dir, main page]

MX352342B - Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof. - Google Patents

Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof.

Info

Publication number
MX352342B
MX352342B MX2013008151A MX2013008151A MX352342B MX 352342 B MX352342 B MX 352342B MX 2013008151 A MX2013008151 A MX 2013008151A MX 2013008151 A MX2013008151 A MX 2013008151A MX 352342 B MX352342 B MX 352342B
Authority
MX
Mexico
Prior art keywords
complex
virus
salmonella
manufacture
benzethonium chloride
Prior art date
Application number
MX2013008151A
Other languages
Spanish (es)
Other versions
MX2013008151A (en
Inventor
Morales Tejeida Braulio
Original Assignee
Moleculas Naturales S A De C V Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moleculas Naturales S A De C V Star filed Critical Moleculas Naturales S A De C V Star
Priority to MX2013008151A priority Critical patent/MX352342B/en
Publication of MX2013008151A publication Critical patent/MX2013008151A/en
Publication of MX352342B publication Critical patent/MX352342B/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to a process for the manufacture of an improved complex of modified benzethonium chloride-diallyl disulphide oxide with the following interaction balance structural formula: (see formula). The complex is a biodegradable and nontoxic long lasting disinfectant with a fast microbial action, since it removes microorganisms in up to 99.999% of gram + and gram - bacteria (Escherichia coli, Salmonella sp, Pseudomonas aeruginosa), as well as fungi (aspergillus niger, candida albicans) and virus. In addition, the invention has an antimicrobial activity for Enterococus feacalis, Salmonela galinarum, Aspergillus niger, Escherichia coli, Candida albicans, Klebsiella pneumoniae, Salmonella pullorura, Newcaste virus, Salmonella typhi, Pasteurella monocytogrnes, Staphylcoccus aureus, Enterococus cloacae, Fumigatus sp, Shigella flexneri, Streptoccocus agalactiae, Aspergillus flavus, Parvo virus, Pseudomona (putida, fluorencens, alcaligenes), Serratia marcenes, Penicillium sp, Vidrio cholerae, Bordetella sp, Erwinia sp, Vidrio cholera, Paramecium Aurelia, Paramecium aurelia, amongst others.
MX2013008151A 2013-07-12 2013-07-12 Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof. MX352342B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2013008151A MX352342B (en) 2013-07-12 2013-07-12 Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013008151A MX352342B (en) 2013-07-12 2013-07-12 Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof.

Publications (2)

Publication Number Publication Date
MX2013008151A MX2013008151A (en) 2013-10-04
MX352342B true MX352342B (en) 2017-11-22

Family

ID=49684404

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008151A MX352342B (en) 2013-07-12 2013-07-12 Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof.

Country Status (1)

Country Link
MX (1) MX352342B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007009796A (en) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel containing pirfenidone.
MX2011007675A (en) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Process for manufacturing a pharmaceutical composition in a sustained-release tablet form containing pirfenidone and the application thereof in the regression of chronic renal failure, breast capsular contracture and liver fibrosis in humans.
MX346763B (en) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne.
MX356551B (en) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Antiseptic, antiseborrheic, exfoliating composition for getting rid of or preventing acne.
MX366086B (en) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V A semi-solid topical composition containing an antimicrobial agent and pirfenidone for the treatment of chronic skin damage.

Also Published As

Publication number Publication date
MX2013008151A (en) 2013-10-04

Similar Documents

Publication Publication Date Title
MX352342B (en) Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof.
BR112012026926B1 (en) hydroxamic acid-derived compound, and pharmaceutical composition, lpxc inhibitor and antimicrobial agent comprising said compound
WO2015002932A8 (en) Antimicrobial compositions comprising hypochlorous acid and silver
JP2015524804A5 (en)
MX366086B (en) A semi-solid topical composition containing an antimicrobial agent and pirfenidone for the treatment of chronic skin damage.
ZA202208862B (en) Cutibacterium acnes strain and medical uses thereof
PE20181359A1 (en) CROP CARE AND PROTECTION COMPOSITION
EA201492081A1 (en) (R) -NIFURAL, ITS APPLICATION IN THE TREATMENT OF INFECTIONS AND SYNTHESIS (R) - AND (S) -NIFURAL
BR112022000070A2 (en) antimicrobial composition
MX367321B (en) Skin care composition and method thereof.
FR2978665B1 (en) ANTISEPTIC COMPOSITION
BR112017004933A2 (en) antimicrobial cleaning composition and method of cleaning or disinfecting a surface
BR112014029430A2 (en) plant disease control agent, method and product
MX2019013120A (en) Composition containing chlorine dioxide and methods for using same.
CL2020000859A1 (en) Gluconic acid derivatives to be used in the treatment and / or prevention of microbial infections.
UA113151C2 (en) APPLICATION OF ANTI-MICROBIAL POLYPEPTIDE COMPOSITION IN THE PRODUCTION OF MEDICINAL PRODUCT
MX2015000761A (en) Improved process for manufacturing a bactericide adduct based on benzethonium chloride, benzalkonium chloride and urea in combination with natural extracts of allicin, the obtained adduct and uses tehreof.
BR112015029447A2 (en) New compound derived from the quamoclit plant and composition containing it as an active ingredient for the prevention or treatment of diabetes.
BR112015032373A2 (en) compositions for water purification and for obtaining biocidal activity in water, and water purification device
UA117200C2 (en) Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol
MX2023008903A (en) Oral care composition comprising oxalic acid.
MY180113A (en) Use of patchouli extract in the preparation of compositions with an anti-microorganism effect
PH12019501839A1 (en) Conjugate of salicylic acid and peptide
BR112015032459A2 (en) antimicrobial agents and uses thereof
WO2012142077A3 (en) Use of propionic acid as an antimicrobial

Legal Events

Date Code Title Description
FG Grant or registration